30 April 2012

Group II Part V: S. Nikkho: Composite Endpoints

All credits to Sylvia Nikkho, Bayer Pharma AG, Berlin, Germany

Presentation at the 2nd PVRI/FDA Conference, Bethesda, Washington DC, April 30-May 1st 2012

 

Additional key-words:  functional class,follow-up,clinical trials

Science that starts with a hello.

Through global collaboration, we make today's work, tomorrow's possibility.

Join the PVRI
standard-example-image.jpg